A strain of Vibrio cholerae non-Ol was isolated from a 48-year-old male in California who presented with a chief complaint of watery diarrhea. Laboratory investigations of this strain revealed the bacterium to be resistant to trimethoprim-sulfamethoxazole and to the vibriostatic agent 0/129 (2,4-diamino-6,7-diisopropylpteridine).
The family Vibrionaceae is composed of oxidase-positive, facultatively anaerobic bacilli that utilize D-glucose as a source of energy and are motile by means of polar flagella (4) . Three genera (Vibrio, Aeromonas, and Plesiomonas) in this family are recognized human pathogens causing a variety of gastrointestinal or extraintestinal diseases. The initial generic identification of members of this group in the clinical laboratory is based upon a small set of differential morphologic and biochemical criteria that include growth on TCBS (thiosulfate-citrate-bile salts) agar and susceptibility to the vibriostatic agent 0/129 (2,4-diamino-6,7-diisopropylpteridine). These last two characteristics are extremely important in the separation of nonhalophilic vibrios, such as Vibrio cholerae, from phenotypically similar organisms, such as members of the genus Aeromonas. In this report, we describe what is to our knowledge the first isolation of a strain of vibriostatic agent 0/129-resistant V. cholerae non-O1 from a patient in the United States.
In September 1991, a 48-year-old male was seen in California by his private physician for an illness, the chief complaint of which was watery diarrhea. Two weeks prior to his visit, he had returned from a trip to Mexico. Fecal cultures taken at the time of his examination yielded a gram-negative curved bacillus that was forwarded to the local public health laboratory for identification. Subsequent testing of this strain by that laboratory indicated an organism that could not be biochemically distinguished between V. cholerae and an Aeromonas species. This strain was then forwarded to the Microbial Diseases Laboratory for definitive identification.
The salient features of this strain are listed in In 1983, Sundaram and Murthy (7) described the first series of human isolates of V. cholerae 01 and non-O1 that were resistant to 10-and 150-,ug disks of 0/129. All of these strains were recovered in India. Follow-up investigations by Matsushita et al. (5) showed this resistance marker to be transferable from 0/129-resistant V. cholerae 01 and non-O1 to 0/129-susceptible V. cholerae. Transconjugants from matings occurred at a frequency of between 10-2 and 10' per donor, and 0/129 resistance was always cotransferred with trimethoprim resistance. These observations suggested that 0/129 resistance might be plasmid encoded and closely linked to trimethoprim resistance. However, a recent study by Huq and colleagues (3) of 32 V. cholerae 01 0/129-resistant strains recovered from plankton and water samples in Bangladesh has failed to support this hypothesis, although universal resistance to both ampicillin and trimethoprimsulfamethoxazole was noted.
Prior to this report, 0/129-resistant V. cholerae non-O1 has been isolated from humans on only two occasions, namely, once from one individual in India and once from two people in Japan. In our case, this is the first apparent isolation of non-O1 V. cholerae resistant to the vibriostatic agent in the Western hemisphere in which the infected individual presumably acquired his isolate while on a trip to Mexico. Like those in previous reports, our 0/129-resistant strain was also resistant to trimethoprim-sulfamethoxazole, further supporting a close association between these two traits.
The most disturbing fact regarding this case report is the (25C, 35C) 
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